DGX Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$245.87median target· current $240.72 (+2.1%)17 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
41 articles · sorted by datePage 1 of 3 · 41 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio25.51Forward 21.93
EPS (TTM)$9.2615.0% YoY
Profit margin9.2%HEALTHCARE
Market cap$26.07BLarge cap
Valuation
- Forward P/E
- 21.93
- PEG ratio
- 2.04
- P/B
- 3.59
- P/S (TTM)
- 2.25
- EV/EBITDA
- 14.54
Profitability & growth
- ROE (TTM)
- 14.6%
- Operating margin
- 15.2%
- Revenue growth YoY
- 10.2%
- Dividend yield
- 1.4%
- Beta
- 0.55
Last earnings
Jul 23, 2026 · Estimate $2.81 · Reported $3.12
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Quest Diagnostics Incorporated
Company profileQuest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 500 PLAZA DRIVE, SECAUCUS, NJ
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$26.07B
Shares outstanding$110.4M
52W high$247.19
52W low$168.97
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent